| Metric | FY 2025 | Prior Q | FY 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $213M | — | — | — | — |
| Op. Income | $4M | — | — | — | — |
| Gross Margin | 55.7% | — | — | — | — |
| Net Margin | 8.4% | — | — | — | — |
| EPS (Diluted) | $0.56 | — | — | — | — |
| Free Cash Flow | $4M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $213M |
| Cost of Revenue | $94M |
| GROSS PROFIT | $119M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $115M |
| Other Expenses | $0 |
| Operating Expenses | $115M |
| Cost & Expenses | $209M |
| OPERATING INCOME | $4M |
| Interest Income | $0 |
| Interest Expense | $2M |
| Other Income/Expenses | $7M |
| INCOME BEFORE TAX | $11M |
| Income Tax Expense | $5M |
| Net Income from Continuing Ops | $6M |
| Net Income from Discontinued Ops | $21M |
| Other Adjustments | $0 |
| NET INCOME | $18M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $18M |
| D&A | $28M |
| EBIT | $13M |
| EBITDA | $41M |
| EPS | -$0 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $213M |
| Cost of Revenue | $94M |
| GROSS PROFIT | $119M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $115M |
| Other Expenses | $0 |
| Operating Expenses | $115M |
| Cost & Expenses | $209M |
| OPERATING INCOME | $4M |
| Interest Income | $0 |
| Interest Expense | $2M |
| Other Income/Expenses | $7M |
| INCOME BEFORE TAX | $11M |
| Income Tax Expense | $5M |
| Net Income from Continuing Ops | $6M |
| Net Income from Discontinued Ops | $21M |
| Other Adjustments | $0 |
| NET INCOME | $18M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $18M |
| D&A | $28M |
| EBIT | $13M |
| EBITDA | $41M |
| EPS | -$0 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $18M |
| Depreciation & Amortization | $30M |
| Stock-Based Compensation | $18M |
| Deferred Income Tax | $5M |
| Other Non-Cash Items | -$12M |
| Change in Working Capital | -$53M |
| OPERATING CASH FLOW | $6M |
| Capital Expenditure | -$2M |
| Acquisitions (Net) | -$11M |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $98M |
| NET CASH FROM INVESTING | $76M |
| Net Debt Issuance | -$26M |
| Common Stock Repurchased | -$38M |
| Common Dividends Paid | $0 |
| Other Financing Activities | -$41M |
| NET CASH FROM FINANCING | -$104M |
| FREE CASH FLOW | $4M |
| Net Change in Cash | -$20M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $67M |
| Short-Term Investments | $0 |
| Net Receivables | $58M |
| Inventory | $3M |
| Other Current Assets | $4M |
| TOTAL CURRENT ASSETS | $138M |
| PP&E (Net) | $12M |
| Goodwill | $248M |
| Intangible Assets | $184M |
| Long-Term Investments | $250.0K |
| Tax Assets | $49M |
| Other Non-Current Assets | $7M |
| TOTAL NON-CURRENT ASSETS | $501M |
| TOTAL ASSETS | $638M |
| Account Payables | $6M |
| Short-Term Debt | $2M |
| Deferred Revenue | $38M |
| Other Current Liabilities | $16M |
| TOTAL CURRENT LIABILITIES | $71M |
| Long-Term Debt | $3M |
| Deferred Revenue NC | $808.0K |
| Deferred Tax Liabilities | $9M |
| Other Non-Current Liabilities | $34M |
| TOTAL NON-CURRENT LIABILITIES | $50M |
| TOTAL LIABILITIES | $121M |
| Common Stock | $3.0K |
| Additional Paid-In Capital | $271M |
| Retained Earnings | $118M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $0 |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $390M |
| Minority Interest | $128M |
| TOTAL EQUITY | $518M |
| TOTAL LIABILITIES & EQUITY | $638M |
| Total Debt | $8M |
| Net Debt | -$59M |
